Boehringer Ingelheim
Boehringer and BioMed X crowdsource top scientists to fight COPD
September 23, 2015Research and Development Boehringer Ingelheim, COPD
Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …
More positive CV data for Boehringer and Lilly’s Jardiance
September 21, 2015Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes
Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …
Boehringer earns NICE nod for IPF drug Ofev
September 14, 2015Sales and Marketing Boehringer Ingelheim, IPF, NICE, idiopathic pulmonary fibrosis
NICE has recommended Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis after the German firm agreed to a …
New Boehringer and Lilly type 2 diabetes treatment gets FDA nod
August 28, 2015Research and Development, Sales and Marketing Boehringer Ingelheim, Eli Lilly, FDA, Synjardy, type 2 diabetes
The FDA has approved Synjardy, from Boehringer Ingelheim and Eli Lilly, for the treatment of adults with type 2 diabetes. …
Lilly and Boehringer launch biosimilar insulin in the UK
August 26, 2015Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly
Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks
August 21, 2015Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs
Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …
Boehringer Ingelheim launches Spiolto for COPD
July 2, 2015Sales and Marketing Boehringer Ingelheim, COPD, Europe, Spiolto, Spiriva, Striverdi
Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …
Boehringer and Vitae Pharma drug fails in mid-stage trial
July 1, 2015Research and Development BI, Boehringer, Boehringer Ingelheim, Vitae Pharmaceuticals, diabetes, type 2 diabetes
A pipeline diabetes drug co-developed by Vitae Pharma and German giants Boehringer Ingelheim has failed to show benefits in a …
Boehringer Ingelheim and Bayer ‘taking the lead’ in social media
April 22, 2015Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld
Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …
Boehringer chases approval for anti-Pradaxa drug
March 3, 2015Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa, bleeding, dabigatran etexilate, idarucizumab
Boehringer Ingelheim is launching new drug applications for its investigational treatment to reverse the effects of its blood-thinning drug Pradaxa. …
Perrigo acquires Omega for $4.5 billion
November 7, 2014Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega
In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …
Boehringer pays $600m for cancer vaccine deal
September 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1
Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …
Boehringer and InterMune data on IPF drugs impress
May 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis
Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …
New managing director for Boehringer Ingelheim UK
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins
Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
Latest content
Five Facts about cardiovascular disease
